1. Home
  2. TXG vs DKL Comparison

TXG vs DKL Comparison

Compare TXG & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$20.54

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

DKL

Delek Logistics Partners

HOLD

Current Price

$47.76

Market Cap

2.4B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
DKL
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Natural Gas Distribution
Sector
Industrials
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TXG
DKL
Price
$20.54
$47.76
Analyst Decision
Hold
Buy
Analyst Count
14
2
Target Price
$15.61
$45.50
AVG Volume (30 Days)
2.3M
65.5K
Earning Date
02-11-2026
02-24-2026
Dividend Yield
N/A
9.38%
EPS Growth
N/A
9.17
EPS
N/A
3.09
Revenue
$641,814,000.00
$967,420,000.00
Revenue This Year
$4.50
$11.84
Revenue Next Year
N/A
$10.55
P/E Ratio
N/A
$15.45
Revenue Growth
1.92
N/A
52 Week Low
$6.78
$34.59
52 Week High
$21.50
$48.97

Technical Indicators

Market Signals
Indicator
TXG
DKL
Relative Strength Index (RSI) 64.64 57.20
Support Level $20.01 $45.28
Resistance Level $21.50 $48.97
Average True Range (ATR) 1.16 1.51
MACD 0.30 0.24
Stochastic Oscillator 83.15 74.00

Price Performance

Historical Comparison
TXG
DKL

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About DKL Delek Logistics Partners

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.

Share on Social Networks: